Free Trial
→ Elon’s BIGGEST warning yet? (From Brownstone Research) (Ad)
OTCMKTS:BICX

Biocorrx 3/31/2025 Earnings Report

Biocorrx logo
$0.36 +0.02 (+5.88%)
As of 06/24/2025 01:41 PM Eastern
ProfileEarnings History

Biocorrx EPS Results

Actual EPS
-$0.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Biocorrx Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Biocorrx Announcement Details

Quarter
Date
3/31/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Biocorrx's next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules.

Conference Call Resources

Biocorrx Earnings Headlines

Biocorrx (BICX) and Its Competitors Critical Analysis
June 23 at 2:13 AM | americanbankingnews.com
BioCorRx Inc. (BICX) Latest Press Releases & Corporate News - Yahoo Finance
June 1, 2025 | finance.yahoo.com
A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
June 25, 2025 | American Alternative (Ad)
BioCorRx Reports Business Update for the First Quarter of 2025
May 20, 2025 | finance.yahoo.com
BioCorRx Pharmaceuticals Inc. Announces That it has Acquired LUCEMYRA(R) (lofexidine), an FDA-Approved Opioid Withdrawal Medication, From USWM, LLC
March 10, 2025 | finance.yahoo.com
La Rosa Holdings Corp. secures new financing, reshuffles leadership
October 6, 2024 | investing.com
See More Biocorrx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biocorrx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biocorrx and other key companies, straight to your email.

About Biocorrx

Biocorrx (OTCMKTS:BICX), through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

View Biocorrx Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles